Genetics, Health Care and Public Policy :An Introduction to Public Health Genetics

Publication subTitle :An Introduction to Public Health Genetics

Author: Alison Stewart; Philippa Brice; Hilary Burton  

Publisher: Cambridge University Press‎

Publication year: 2007

E-ISBN: 9780511282751

P-ISBN(Paperback): 9780521529075

Subject: Q987 human genetics

Keyword: 预防医学、卫生学

Language: ENG

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Genetics, Health Care and Public Policy

Description

Genetics, Health Care and Public Policy is an introduction to the new discipline of public health genetics. It brings together the insights of genetic and molecular science as a means of protecting and improving the health of the population. Its scope is wide and requires an understanding of genetics, epidemiology, public health and the principles of ethics, law and the social sciences. This book sets out the basic principles of public health genetics for a wide audience from those providing health care to those involved in establishing policy. The emphasis throughout the text is on providing an accessible introduction to the field. The content moves from the basic concepts, including definitions and history, through chapters on genetics, genetic technology, epidemiology, genetics in medicine, genetics in health services, ethical, legal and social implications, to the implications for health policy. It provides one-stop, introductory coverage of this rapidly developing and multidisciplinary field.

Chapter

Further reading and resources

Principles of public health

The emergence of public health genetics

The human genome project and ‘genomic medicine’

Community genetics

Current developments in public health genetics

Genomics and global health

2 Genetic science and technology

Basic molecular genetics

Genes and the genome

Chromosomes

The ‘central dogma’: DNA makes RNA makes protein

Gene structure and expression in more detail

The complexity of the genetic programme

Genetic variation: mutation and polymorphism

Cell division and the maintenance of the genome

Meiosis and recombination: the formation of sex cells

Inheritance patterns

Genes and disease

Mendelian (‘single-gene’) diseases

Mitochondrial disorders

Chromosomal disorders

Diseases caused by disorders in epigenetic mechanisms

Mendelian subsets of common diseases

Multifactorial disease

Cancer

Some complexities of the relationship between genes and disease

Penetrance

Inherited and new mutations

Genetic heterogeneity

Variable expressivity

Genetic technology

Cutting and joining pieces of DNA

Separating pieces of DNA in a mixture

Detecting specific sequences: hybridisation

Fluorescent in situ hybridisation (FISH)

DNA cloning and clone libraries

The polymerase chain reaction

DNA sequencing

DNA microarrays

Markers and maps

The human genome project

Mapping human genetic variation: SNPs and haplotypes

The post-genome challenge

Identifying genes and studying gene function

Proteomics

Comparative genomics

Bioinformatics

Systems biology

Epidemiological and biomedical informatics

Further reading and resources

Basic genetics

Genes and disease

Genomics and the human genome project

The post-genome challenge

3 Fundamentals of genetic epidemiology

An overview of classical epidemiology

Causation and association

Measuring the occurrence of illness

Measuring associations in analytical epidemiology

Relative measures

Absolute measures

Attributable fraction and population attributable fraction

Cohort and case–control studies

Cohort studies

Case–control studies

Interaction

Genetic epidemiology and human disease

Genetic variation and disease susceptibility

Clustering in families and the familial relative risk

Using heritability to assess genetic and environmental contributions

Interpreting heritability

Twin studies

Adoption studies

Determining the genetic model of inheritance: segregation analysis

Problems with segregation analysis

Identifying specific genetic determinants related to disease susceptibility

Linkage and linkage analysis

Model-based linkage analysis

Using linkage to find disease loci

Model-free linkage analysis

Association analysis

Interpreting statistically significant results from gene–disease association studies

Type I statistical error and false-positive results

Linkage disequilibrium

Confounding in genetic association studies (population stratification)

Family-based association studies and the transmission disequilibrium test

Haplotype analysis in association studies

Genome-wide association and the candidate gene approach

The candidate gene approach

Defining the phenotype in association studies

Conclusion: linkage and association are complementary approaches

Systematic review and meta-analysis of genetic association studies

Evaluating the characteristics of disease-susceptibility genetic variants

Identifying whether gene variants are pathogenic variants

Estimating disease allele frequency

Estimating penetrance

Gene–gene interactions

Gene–environment interactions

Study designs for gene–environment interactions

Gene–environment interactions and Mendelian randomisation

Further reading and resources

Classical epidemiology

Genetic epidemiology

Systematic review and meta-analysis

4 Genetics in medicine

Genetic testing

Diagnostic genetic testing

Carrier testing

Predictive genetic testing

Testing for genetic susceptibility

Population screening

Methods of genetic testing

Cytogenetic testing

DNA testing

Techniques for finding mutations

Electrophoresis-based methods

PCR-based detection

Comparative genomic hybridisation

Denaturing high-performance liquid chromatography (DHPLC)

MALDI-TOF

Future developments

Evaluation of genetic tests

Challenges for evaluating genetic tests

Genetics and disease prevention

Genotypic and phenotypic prevention

Identifying individuals at high genetic risk: family tracing

Susceptibility genetics

Family history as a tool in prevention of common disease

Ecogenetics

Nutrigenetics and nutrigenomics

Genetics and disease management

Pharmacogenetics

Heritable pharmacogenetic variation

SNP profiling in pharmacogenetics

Problems and prospects for pharmacogenetics

Molecular genetic profiling in diagnosis and disease management

Gene therapy

Gene therapy methods

Gene therapy for single-gene disease

Gene therapy for cancer

Safety of gene therapy

RNA therapies

Stem cell therapy

Cell nuclear transfer and ‘therapeutic cloning’

Genetics and infectious disease

Pathogen genetics

‘Host’ genetics

Further reading and resources

Genetic testing and screening

Genetics and disease prevention

Genetics and disease management

5 Genetics in health services

Organisation of clinical genetics services in the UK

The multidisciplinary clinical team

The clinical geneticist

The genetic counsellor

The clinical genetics consultation

Cancer genetics

Cardiac genetics

Neurogenetics

Genetic registers

Laboratory genetics services

Molecular genetics

Cytogenetics

Biochemical genetics

Some services closely associated with genetics centres

Inherited metabolic disease

Haemoglobinopathies

Inherited bleeding disorders

The role of voluntary organisations

Commissioning of genetics services

Population screening programmes for genetic conditions

Antenatal Down syndrome screening

Haemoglobinopathy screening

Neonatal cystic fibrosis screening

Neonatal screening for inborn errors of metabolism

Population carrier screening in specific communities

Genetics in mainstream medicine

Genetics in other specialist services: the multidisciplinary approach

Development of service models for cancer genetics

National Service Frameworks

Genetics in primary care

The future of genetics in clinical services

Further reading and resources

Organisation and development of genetic services

Voluntary organisations

Commissioning of genetics services

Population screening

Genetics in mainstream medicine

6 Ethical, legal and social implications of genetics

Genetic determinism and reductionism

Geneticisation

The legacy of eugenics

Genetics and reproductive choice

Antenatal genetic testing and screening

Limits to reproductive choice?

Genetic enhancement

Genetics and assisted reproduction

Reproductive cloning

Embryo research and embryonic stem cells

Genetic information

Genetic exceptionalism

Genetic databases

Consent

Confidentiality

Role of the commercial sector

Feedback to participants

Genetic discrimination

Genetic information and insurance

Genetic information and employment

Justice and the ‘genetic underclass’

Genetics and racial discrimination

Ethical and legal aspects of clinical genetics

Confidentiality versus the duty to warn

The right not to know

Consent to genetic testing

Testing of children

Testing of adults lacking capacity to consent

Public perceptions of genetics

Further reading and resources

Genetic reductionism, geneticisation and eugenics

Genetics and reproductive choice

Genetics and assisted reproduction

Embryo research and embryonic stem cells

Genetic information

Genetic discrimination

Ethical and legal aspects of clinical genetics

Public perceptions of genetics

7 Policy implications

How government policy for genetics is developed in the UK

The advisory and regulatory system for genetics

The international context for genetics policy

Policy for key issues in genetics

Genetics in reproductive decision-making

Antenatal genetic testing

Pre-implantation genetic diagnosis

Population screening programmes

Assisted reproduction technologies

Consent to genetic testing and analysis

The Human Tissue Act 2004

Research on samples from individuals who lack the capacity to consent

Privacy and confidentiality of genetic information

The legislative framework for the use of medical information in research

The interpretation of data protection law

Federal legislation in the US

Specific protection for genetic information

Genetic information and current data protection law

Protection against unfair discrimination

Insurance

Employment

Regulating the availability of genetic tests

Market authorisation

Laboratory regulation

Advertising and over-the-counter tests

Regulatory mechanisms within healthcare services

Practice guidelines

Pharmacogenetics

Regulation of pharmacogenetic tests

Pharmacogenetics in drug development

Broader policy considerations

Regulation of gene-based and cellular therapies

Policy for embryonic stem cell research

Regulation of therapeutic cell- and tissue-based materials

Market authorisation of ‘advanced therapies’

Clinical trials and research governance

General governance of clinical research

Intellectual property and patents

General policy issues

The scientific and clinical research base

Research capacity

EU research policy

Public health policy

The role of the commercial sector

Financial considerations and health economics

Education and training

The public

Concluding remarks

Further reading and resources

Policy development for genetics in the UK

The international context

Genetics in reproductive decision-making

Assisted reproduction

Consent to genetic testing and analysis

Protection of medical and genetic information

Protection against unfair discrimination

Regulation of genetic tests

Pharmacogenetics: policy issues

Advanced therapies

Clinical trials and research governance

Intellectual property and patents

General policy issues

Scientific and clinical research policy, and relationships between the public and private sectors

Health economics

Education and training

Public involvement

Challenges for public health genetics

Further reading

Books, reports and journal papers

Websites and web pages

Index

The users who browse this book also browse


No browse record.